Storia in 6 fonti

Foundayo and Zepbound now covered for millions of Americans

Raccontata da

biopharmadive.com

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

morningstar.comStai leggendo3 mesi fa

Foundayo and Zepbound now covered for millions of Americans

originale

upi.com

Timeline cronologica

giovedì 28 maggio 2026·biopharmadive.com
CVS obesity drug deal puts Lilly on equal footing with Novo
The agreement includes Lilly’s new pill Foundayo and restores coverage for Zepbound, erasing what had been a commercial edge for rival Novo Nordisk.
giovedì 28 maggio 2026·morningstar.com
Foundayo and Zepbound now covered for millions of Americans
Foundayo and Zepbound now covered for millions of Americans

3 mesi fa

CVS Caremark to cover Foundayo, Zepbound obesity drugs - UPI.com

CVS Caremark will start covering Eli Lilly's Foundayo and resume covering its Zepbound obesity drugs in the next several months, the companies said.

Leggi questa versione → originale

qz.com3 mesi fa

CVS Caremark adds Zepbound and Foundayo to formulary

The pharmacy benefit manager dropped Zepbound a year ago in favor of rival Wegovy — now both Lilly and Novo Nordisk drugs will be co-preferred options

Leggi questa versione → originale

endpoints.news3 mesi fa

Lilly's Foundayo and Zepbound to gain CVS coverage, lifting sales outlook

Lilly's Foundayo and Zepbound gain CVS Caremark formulary coverage, expanding access for 90 million members at $25 monthly co-pays.

Leggi questa versione → originale

cnbc.com3 mesi fa

CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans

CVS will add Zepbound coverage on Oct. 1, and start covering Lilly's newly approved Foundayo pill on June 1.

Leggi questa versione → originale

biopharmadive.com3 mesi fa

CVS obesity drug deal puts Lilly on equal footing with Novo

The agreement includes Lilly’s new pill Foundayo and restores coverage for Zepbound, erasing what had been a commercial edge for rival Novo Nordisk.

Leggi questa versione → originale

giovedì 28 maggio 2026·

cnbc.com

CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans

CVS will add Zepbound coverage on Oct. 1, and start covering Lilly's newly approved Foundayo pill on June 1.

giovedì 28 maggio 2026·

qz.com

CVS Caremark adds Zepbound and Foundayo to formulary

The pharmacy benefit manager dropped Zepbound a year ago in favor of rival Wegovy — now both Lilly and Novo Nordisk drugs will be co-preferred options

giovedì 28 maggio 2026·

endpoints.news

Lilly's Foundayo and Zepbound to gain CVS coverage, lifting sales outlook

Lilly's Foundayo and Zepbound gain CVS Caremark formulary coverage, expanding access for 90 million members at $25 monthly co-pays.

giovedì 28 maggio 2026·

upi.com

CVS Caremark to cover Foundayo, Zepbound obesity drugs - UPI.com

CVS Caremark will start covering Eli Lilly's Foundayo and resume covering its Zepbound obesity drugs in the next several months, the companies said.